Keywords: long-term, use, cisapride, uk, janssen, pharmaceuticals, received

LONG-TERM USE OF CISAPRIDE IN UK

Article | 18 January 1993

Print This

Janssen Pharmaceuticals has received approval in the UK to market its prokinetic agent Prepulsid (cisapride) for the maintenance treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in